From January 1992 to December 1997, 21 consecutive patients (14 SAA, 3 SCID
, 1 Fanconi anemia, 1 Diamond-Blackfan anemia, 1 mucolipidosis and 1. mucop
olysaccharidosis type I,) were transplanted (16 HLA-id, family, 2 MUD and 3
haploidentical family donors) in a single center. The median follow up per
iod is 41 months (range 7-76), The probability of 3.5 year overall disease
free survival is 14/21 (67%), the transplant related mortality is 4/21 (19%
), All the SCID patients are alive and disease free. 3 SAP patients had sig
ns of fungal infection prior to transplant. They died in spite of intensive
antifungal treatment resulting reduced DFS for SAA to 71%, Two patients wi
th lysosomal storage disorders (mucolipidosis and MPS I.) rejected the hapl
oidentical T-cell depleted graft 1 and 11 months after transplant, respecti
vely. In 2 cases non-engraftment occured, both patients were retranslplante
d succesfully.